Proposed Collection; 60-Day Comment Request Surveys and Interviews to Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program (NCI), 15541-15542 [2016-06477]
Download as PDF
<![CDATA[
15541
Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
Dated: March 17, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–06480 Filed 3–22–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request Autism Spectrum Disorder
(ASD) Research Portfolio Analysis,
NIMH
Summary: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Institute of Mental Health
(NIMH), National Institutes of Health
(NIH), will publish periodic summaries
of proposed projects to be submitted to
the Office of Management and Budget
(OMB) for review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
Proposed Collection: Autism
Spectrum Disorder (ASD) Research
Portfolio Analysis, 0925–0682,
Expiration Date 9/30/2016,
EXTENSION, National Institute of
Mental Health (NIMH), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The purpose of the ASD
portfolio analysis is to collect research
funding data from U.S. and
international ASD research funders, to
assist the Interagency Autism
Coordinating Committee (IACC) in
fulfilling the requirements of the
Combating Autism Act, and to inform
the committee and interested
stakeholders of the funding landscape
and current directions for ASD research.
Specifically, these analyses will
continue to examine the extent to which
current funding and research topics
align with the IACC Strategic Plan for
ASD Research. The findings will help
guide future funding priorities by
outlining current gaps and opportunities
in ASD research as well as serving to
highlight annual activities and research
progress.
OMB approval is requested for three
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
520.
whether the information will have
practical utility; the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
ways to enhance the quality, utility, and
clarity of the information to be
collected; and ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: The Office of Autism
Research Coordination, NIMH, NIH,
Neuroscience Center, 6001 Executive
Blvd., MSC 9663, Room 6184, Bethesda,
Maryland 20892, Or you can Email your
request, including your address to:
iaccpublicinquiries@mail.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total annual
burden hour
U.S. Federal .....................................................................................................
U.S. Private ......................................................................................................
International Government ................................................................................
International Private .........................................................................................
22
8
4
4
63
75
14
9
15/60
15/60
15/60
15/60
347
150
14
9
Total ..........................................................................................................
38
2078
........................
520
Dated: March 17, 2016.
Melba Rojas,
Project Clearance Liaison, NIMH, NIH.
[FR Doc. 2016–06483 Filed 3–22–16; 8:45 am]
jstallworth on DSK7TPTVN1PROD with NOTICES
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request Surveys and Interviews to
Support an Evaluation of the
Innovative Molecular Analysis
Technologies (IMAT) Program (NCI)
In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
SUMMARY:
VerDate Sep<11>2014
15:26 Mar 22, 2016
Jkt 238001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited to address one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
The quality, utility, and clarity of the
information to be collected; and (4)
Minimize the burden of the collection of
E:\FR\FM\23MRN1.SGM
23MRN1
15542
Federal Register / Vol. 81, No. 56 / Wednesday, March 23, 2016 / Notices
information on those who are to
respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
To Submit Comments and For Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Anthony Dickherber,
NCI Center for Strategic Scientific
Initiatives, 31 Center Drive, Rm10A33,
Bethesda, MD 20892 or call non-toll-free
number 301–547–9980 or Email your
request, including your address to:
dickherberaj@mail.nih.gov. Formal
requests for additional plans and
instruments must be requested in
writing.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: Surveys and
Interviews to Support an Evaluation of
the Innovative Molecular Analysis
Technologies (IMAT) Program (NCI),
0925–0720, Expiration Date 5/31/2016—
EXTENSION, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
to accommodate unforeseen delays in
collecting the remaining information.
Like all institutes and centers (ICs) of
the NIH, NCI seeks opportunities for
improving their programs’ utility for the
broad continuum of researchers,
clinicians and ultimately patients. NCI
Acting Director Douglas Lowy and other
leadership across NCI, as well as the
NCI Board of Scientific Advisors, will
be the primary users of the evaluation
results. Findings are primarily intended
for considering the long-term strategy to
support innovative technology
development and how to more
efficiently translate emerging
capabilities through such technologies
into the promised benefits for cancer
research and clinical care. Interviews
with grantees, program officers, review
officers, and other NIH awardees make
up a crucial component of the
evaluation plan and will largely follow
set survey protocols. Specific near-term
aims include the use of this information
to consider the utility of continued
investment through existing
solicitations and in strategic planning
generally for institute support for
innovative technology development.
OMB approval is requested for 1 year.
There are no costs to respondents other
than their time. The total estimated
annualized burden hours are 233.
Need and Use of Information
Collection: The purpose of the proposed
evaluation is to pursue a comprehensive
process and outcome assessment of the
15-year old Innovative Molecular
Analysis Technologies (IMAT) program.
While the program consistently offers
promising indicators of success, the full
program has not been evaluated since
2008, and never in as comprehensive a
manner as has been formulated in the
current evaluation plan. An outcome
evaluation of the long-standing National
Cancer Institute’s (NCI) IMAT program
presents a rich and unique opportunity
likely to serve institutes across the
National Institutes of Health (NIH), and
perhaps other federal agencies,
considering the costs and benefits of
directing resources towards supporting
technology development. An award
through the NIH Evaluation Set-Aside
program to support this evaluation, for
which NIH-wide relevance is a principle
element of determining merit for
support, is testament to this. The
evaluation serves as an opportunity to
gauge the impact of investments in
technology development and also to
assess the strengths and weaknesses of
phased innovation award mechanisms.
Prior approval from OMB allowed for
extensive surveys and interviews
already, and this extension is requested
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total annual
burden
(in hours)
Form name
Type of respondents
Interview—IMAT Grantee .................
Web-based
Survey—Technology
Grantees.
18
379
1
1
1
30/60
18
190
Interview—Tech End-Users ..............
IMAT Awardees ................................
IMAT Awardees; Other NIH Awardees
representing
comparison
group.
Technology End-Users .....................
50
1
30/60
25
Totals .........................................
...........................................................
447
447
........................
233
Dated: March 16, 2016.
Karla Bailey,
NCI Project Clearance Liaison. National
Institutes of Health.
[FR Doc. 2016–06477 Filed 3–22–16; 8:45 am]
BILLING CODE 4140–01–P
jstallworth on DSK7TPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2); notice
VerDate Sep<11>2014
15:26 Mar 22, 2016
Jkt 238001
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The purpose of this
meeting is to evaluate requests for
preclinical development resources for
potential new therapeutics for the
treatment of cancer. The outcome of the
evaluation will provide information to
internal NCI committees that will
decide whether NCI should support
requests and make available contract
resources for development of the
potential therapeutic to improve the
treatment of various forms of cancer.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Feb 2016
Cycle 22 NExT SEP Committee Meeting.
Date: April 27, 2016.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To evaluate the NCI Experimental
Therapeutics Program Portfolio.
Place: National Institutes of Health, 9000
Rockville Pike, Campus Building 31,
E:\FR\FM\23MRN1.SGM
23MRN1
]]>Agencies
[Federal Register Volume 81, Number 56 (Wednesday, March 23, 2016)]
[Notices]
[Pages 15541-15542]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06477]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request Surveys and
Interviews to Support an Evaluation of the Innovative Molecular
Analysis Technologies (IMAT) Program (NCI)
SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995, for opportunity for public comment
on proposed data collection projects, the National Cancer Institute
(NCI), National Institutes of Health (NIH), will publish periodic
summaries of proposed projects to be submitted to the Office of
Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited to address one or more of the following points:
(1) Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) The quality, utility, and clarity of the information to be
collected; and (4) Minimize the burden of the collection of
[[Page 15542]]
information on those who are to respond, including the use of
appropriate automated, electronic, mechanical, or other technological
collection techniques or other forms of information technology.
To Submit Comments and For Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project, contact: Anthony
Dickherber, NCI Center for Strategic Scientific Initiatives, 31 Center
Drive, Rm10A33, Bethesda, MD 20892 or call non-toll-free number 301-
547-9980 or Email your request, including your address to:
dickherberaj@mail.nih.gov. Formal requests for additional plans and
instruments must be requested in writing.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: Surveys and Interviews to Support an
Evaluation of the Innovative Molecular Analysis Technologies (IMAT)
Program (NCI), 0925-0720, Expiration Date 5/31/2016--EXTENSION,
National Cancer Institute (NCI), National Institutes of Health (NIH).
Need and Use of Information Collection: The purpose of the proposed
evaluation is to pursue a comprehensive process and outcome assessment
of the 15-year old Innovative Molecular Analysis Technologies (IMAT)
program. While the program consistently offers promising indicators of
success, the full program has not been evaluated since 2008, and never
in as comprehensive a manner as has been formulated in the current
evaluation plan. An outcome evaluation of the long-standing National
Cancer Institute's (NCI) IMAT program presents a rich and unique
opportunity likely to serve institutes across the National Institutes
of Health (NIH), and perhaps other federal agencies, considering the
costs and benefits of directing resources towards supporting technology
development. An award through the NIH Evaluation Set-Aside program to
support this evaluation, for which NIH-wide relevance is a principle
element of determining merit for support, is testament to this. The
evaluation serves as an opportunity to gauge the impact of investments
in technology development and also to assess the strengths and
weaknesses of phased innovation award mechanisms. Prior approval from
OMB allowed for extensive surveys and interviews already, and this
extension is requested to accommodate unforeseen delays in collecting
the remaining information.
Like all institutes and centers (ICs) of the NIH, NCI seeks
opportunities for improving their programs' utility for the broad
continuum of researchers, clinicians and ultimately patients. NCI
Acting Director Douglas Lowy and other leadership across NCI, as well
as the NCI Board of Scientific Advisors, will be the primary users of
the evaluation results. Findings are primarily intended for considering
the long-term strategy to support innovative technology development and
how to more efficiently translate emerging capabilities through such
technologies into the promised benefits for cancer research and
clinical care. Interviews with grantees, program officers, review
officers, and other NIH awardees make up a crucial component of the
evaluation plan and will largely follow set survey protocols. Specific
near-term aims include the use of this information to consider the
utility of continued investment through existing solicitations and in
strategic planning generally for institute support for innovative
technology development.
OMB approval is requested for 1 year. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 233.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Type of Number of Number of burden per Total annual
Form name respondents respondents responses per response (in burden (in
respondent hours) hours)
----------------------------------------------------------------------------------------------------------------
Interview--IMAT Grantee....... IMAT Awardees... 18 1 1 18
Web-based Survey--Technology IMAT Awardees; 379 1 30/60 190
Grantees. Other NIH
Awardees
representing
comparison
group.
Interview--Tech End-Users..... Technology End- 50 1 30/60 25
Users.
---------------------------------------------------------------------------------
Totals.................... ................ 447 447 .............. 233
----------------------------------------------------------------------------------------------------------------
Dated: March 16, 2016.
Karla Bailey,
NCI Project Clearance Liaison. National Institutes of Health.
[FR Doc. 2016-06477 Filed 3-22-16; 8:45 am]
BILLING CODE 4140-01-P
